bioRxiv · 10.64898/2026.08.26.747402
Disrupted neuropeptide-signaling drives enduring reward deficits after early-life stress
Abstract
Whereas brain systems mediating acute stress are essential for survival, chronic early-life stress (ELA) may lead to poor ability to experience pleasure (anhedonia), a core feature of depression. For decades, the stress neuropeptide corticotropin-releasing hormone (CRH) has been a target for treating depression. However the failure of several clinical trials blocking CRH receptor1 (CRHR1) has left the therapeutic role of CRH signaling a major unresolved mystery. Here, we uncover the signaling plasticity behind this enigma with the use of in vivo G protein-coupled activation-based (GRAB) imaging and viral-genetic and pharmacological mechanistic manipulations. We find that CRH signaling via CRHR1 indeed disrupts reward behaviors in control mice, but is disrupted in anhedonic mice with a history of ELA. Instead, activation of CRH receptor 2 (CRHR2) reverses anhedonia-like behaviors in adult ELA mice. These findings redefine our understanding of stress-mediated anhedonia and provide a precise, novel therapeutic target for stress-related mental illness.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Birnie, M. T., Taniguchi, L., Harvey, L. M., Tetzlaff, M., Mattioni, L., Floriou-Servou, A., Thiagarajan, N., Angeles, g., Daglian, J., Chen, Y., Baram, T. Z.. 2026-08-27. Disrupted neuropeptide-signaling drives enduring reward deficits after early-life stress. https://doi.org/10.64898/2026.08.26.747402
Cite the original work for its findings. Save a collection to share your selection of sources.